| |
|
|
|
Aldeyra Therapeu  
|
|
6.71 -0.23 (-0.03%) |
12-01 16:00 |
|
Open: |
7.16 |
Pre close: |
7.03 |
Target:
|
8.05 
|
|
High: |
7.17 |
Low: |
6.69 |
Resistance:
|
6.89
7.31
|
|
Volume: |
359,845 |
Market Cap: |
260M |
Support:
|
6.21
5.17
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
6.82
 |
MACD |
MACD(12,26):
|
-0.03 |
|
MA(20): |
6.75 |
Signal(12,26,9): |
-0.06 |
|
MA(100): |
6.81 |
Stochastic Oscillator |
%K(14,3):
|
61.05 |
|
MA(250): |
5.28 |
%D(3): |
57.71 |
|
Average Volume(K) |
3-Month: |
52655
|
52-Week |
High:
|
8.70 |
|
10-Days: |
31295 |
Low: |
1.48 |
|
RSI |
RSI(14):
|
47.22 |
Change(%): |
40.7 |
|
Financials, Statistics and Valuation |
|
EPS |
-2.240 |
Return on Equity (ttm) |
-65.7 |
Shares Out. (M) |
38.82 |
|
EPS Est. Current Year |
-1.470 |
Return on Assets (ttm) |
-28.6 |
Shares Float (M) |
29.21 |
|
EPS Est. Next Year |
-1.740 |
PEG Ratio |
0.00 |
% Held by Insiders |
2.22 |
|
EPS Est. Next Quarter |
-0.370 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
51.30 |
|
Forward EPS |
-2.240 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
1570 |
|
Book Value (p.s.) |
1.680 |
EBITDA (p.s.) |
-0.972 |
P/E |
-3.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
3.99 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-40.40 |
P/S |
0.00 |
|
Operating Margin |
0.00 |
Levered Free Cash Flow
(M) |
-14.30 |
P/CF |
-6.45 |
|
|
|
|
|
|
